Allworth Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Sell |
46
-98
| -68% | -$23.7K | ﹤0.01% | 2835 |
|
|
2025
Q1 | $36K | Buy |
144
+104
| +260% | +$26K | ﹤0.01% | 1721 |
|
|
2024
Q4 | $14.4K | Buy |
40
+1
| +3% | +$361 | ﹤0.01% | 2293 |
|
|
2024
Q3 | $13K | Sell |
39
-6
| -13% | -$2.01K | ﹤0.01% | 2143 |
|
|
2024
Q2 | $13.4K | Sell |
45
-12
| -21% | -$3.56K | ﹤0.01% | 2102 |
|
|
2024
Q1 | $19.7K | Buy |
57
+11
| +24% | +$3.81K | ﹤0.01% | 1782 |
|
|
2023
Q4 | $14.9K | Sell |
46
-35
| -43% | -$11.3K | ﹤0.01% | 1809 |
|
|
2023
Q3 | $29K | Buy |
81
+10
| +14% | +$3.59K | ﹤0.01% | 1322 |
|
|
2023
Q2 | $26.9K | Sell |
71
-22
| -24% | -$8.34K | ﹤0.01% | 1368 |
|
|
2023
Q1 | $44.5K | Buy |
93
+37
| +66% | +$17.7K | ﹤0.01% | 1110 |
|
|
2022
Q4 | $23.5K | Sell |
56
-83
| -60% | -$34.9K | ﹤0.01% | 1285 |
|
|
2022
Q3 | $58K | Buy |
139
+112
| +415% | +$46.7K | ﹤0.01% | 906 |
|
|
2022
Q2 | $13K | Buy |
27
+25
| +1,250% | +$12K | ﹤0.01% | 1426 |
|
|
2022
Q1 | $1K | Sell |
2
-22
| -92% | -$11K | ﹤0.01% | 1882 |
|
|
2021
Q4 | $18K | Buy |
+24
| New | +$18K | ﹤0.01% | 1154 |
|
|
2021
Q2 | – | Sell |
-70
| Closed | -$40K | – | 1550 |
|
|
2021
Q1 | $40K | Hold |
70
| – | – | ﹤0.01% | 617 |
|
|
2020
Q4 | $41K | Hold |
70
| – | – | ﹤0.01% | 514 |
|
|
2020
Q3 | $36K | Hold |
70
| – | – | ﹤0.01% | 467 |
|
|
2020
Q2 | $32K | Hold |
70
| – | – | ﹤0.01% | 491 |
|
|
2020
Q1 | $25K | Hold |
70
| – | – | ﹤0.01% | 523 |
|
|
2019
Q4 | $26K | Buy |
+70
| New | +$26K | ﹤0.01% | 472 |
|